Clinical Trial Update: Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Hydronidone for liver fibrosis associated with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Drugs mentioned

• Hydronidone (Hydronidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Liver Fibrosis | Phase 3 | Status: COMPLETED